Uni Super Management Pty LTD Vertex Pharmaceuticals Inc Transaction History
Uni Super Management Pty LTD
- $11.9 Billion
- Q2 2024
A detailed history of Uni Super Management Pty LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Uni Super Management Pty LTD holds 12,057 shares of VRTX stock, worth $5.85 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
12,057
Previous 5,832
106.74%
Holding current value
$5.85 Million
Previous $2.44 Billion
99.77%
% of portfolio
0.05%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding VRTX
# of Institutions
1,707Shares Held
226MCall Options Held
1.2MPut Options Held
1.59M-
Capital World Investors Los Angeles, CA26.7MShares$13 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$11.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.3 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.69 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4.15 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $125B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...